PL348721A1 - Use of phosphonoformic acid derivatives for treating infections - Google Patents
Use of phosphonoformic acid derivatives for treating infectionsInfo
- Publication number
- PL348721A1 PL348721A1 PL99348721A PL34872199A PL348721A1 PL 348721 A1 PL348721 A1 PL 348721A1 PL 99348721 A PL99348721 A PL 99348721A PL 34872199 A PL34872199 A PL 34872199A PL 348721 A1 PL348721 A1 PL 348721A1
- Authority
- PL
- Poland
- Prior art keywords
- acid derivatives
- treating infections
- phosphonoformic acid
- phosphonoformic
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19854402A DE19854402A1 (en) | 1998-11-25 | 1998-11-25 | Use of phosphonoformic acid derivatives for the therapeutic and prophylactic treatment of infections |
| PCT/EP1999/008965 WO2000030625A2 (en) | 1998-11-25 | 1999-11-20 | Use of phosphonoformic acid derivatives for treating infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL348721A1 true PL348721A1 (en) | 2002-06-03 |
Family
ID=7888997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99348721A PL348721A1 (en) | 1998-11-25 | 1999-11-20 | Use of phosphonoformic acid derivatives for treating infections |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1131075A2 (en) |
| JP (1) | JP2002530326A (en) |
| CN (1) | CN1328465A (en) |
| AP (1) | AP2001002165A0 (en) |
| AU (1) | AU1555600A (en) |
| BR (1) | BR9915639A (en) |
| CA (1) | CA2352549A1 (en) |
| CZ (1) | CZ20011821A3 (en) |
| DE (1) | DE19854402A1 (en) |
| EA (1) | EA200100586A1 (en) |
| IL (1) | IL142776A0 (en) |
| NO (1) | NO20012541L (en) |
| OA (1) | OA11717A (en) |
| PL (1) | PL348721A1 (en) |
| TR (1) | TR200101433T2 (en) |
| WO (1) | WO2000030625A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060166941A1 (en) * | 2003-03-14 | 2006-07-27 | Epistem Limited | Treatment and/or prevention of non-viral epithelial damage |
| US20050171063A1 (en) * | 2003-10-20 | 2005-08-04 | Pawan Malhotra | Use of phosphono derivatives as anti-malarials |
| US9808011B2 (en) | 2014-12-15 | 2017-11-07 | Biovectra Inc. | Pentacyclic triterpene compounds and uses thereof |
| CN105794493A (en) * | 2016-03-11 | 2016-07-27 | 钦州市凤源泉生物科技有限公司 | Culture method for improving main active components of russule |
| KR101797926B1 (en) * | 2016-11-21 | 2017-11-15 | 한국식품연구원 | Composition for preventing or treating obesity or obesity-realated metabolic syndrome comprising formic acid or pharmaceutically acceptable salt thereof as an active ingredient |
| KR101912774B1 (en) * | 2016-11-21 | 2018-10-29 | 한국식품연구원 | Composition comprising a strain having formic acid producing ability for the preventing or treatment of obesity, or obesity-realated metabolic syndrome |
| CN108948005A (en) * | 2018-07-03 | 2018-12-07 | 湖南华腾制药有限公司 | Polyethyleneglycol modified Enoxacin and application |
| KR102641583B1 (en) * | 2018-10-23 | 2024-02-28 | 건국대학교 산학협력단 | Composition for preventing plant diseases comprising zidovudine |
| CN114983999A (en) * | 2022-06-09 | 2022-09-02 | 四川大学 | New application and verification method of artemisinin and derivatives thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9603726D0 (en) * | 1996-10-11 | 1996-10-11 | Astra Ab | Novel compounds |
-
1998
- 1998-11-25 DE DE19854402A patent/DE19854402A1/en not_active Ceased
-
1999
- 1999-11-20 CZ CZ20011821A patent/CZ20011821A3/en unknown
- 1999-11-20 PL PL99348721A patent/PL348721A1/en unknown
- 1999-11-20 WO PCT/EP1999/008965 patent/WO2000030625A2/en not_active Application Discontinuation
- 1999-11-20 CA CA002352549A patent/CA2352549A1/en not_active Abandoned
- 1999-11-20 TR TR2001/01433T patent/TR200101433T2/en unknown
- 1999-11-20 CN CN99813703A patent/CN1328465A/en active Pending
- 1999-11-20 EA EA200100586A patent/EA200100586A1/en unknown
- 1999-11-20 AP APAP/P/2001/002165A patent/AP2001002165A0/en unknown
- 1999-11-20 EP EP99958099A patent/EP1131075A2/en not_active Withdrawn
- 1999-11-20 AU AU15556/00A patent/AU1555600A/en not_active Abandoned
- 1999-11-20 BR BR9915639-3A patent/BR9915639A/en not_active IP Right Cessation
- 1999-11-20 JP JP2000583508A patent/JP2002530326A/en active Pending
- 1999-11-20 OA OA1200100129A patent/OA11717A/en unknown
- 1999-11-20 IL IL14277699A patent/IL142776A0/en unknown
-
2001
- 2001-05-23 NO NO20012541A patent/NO20012541L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002530326A (en) | 2002-09-17 |
| AU1555600A (en) | 2000-06-13 |
| CZ20011821A3 (en) | 2001-09-12 |
| EP1131075A2 (en) | 2001-09-12 |
| DE19854402A1 (en) | 2000-05-31 |
| NO20012541L (en) | 2001-07-24 |
| NO20012541D0 (en) | 2001-05-23 |
| CA2352549A1 (en) | 2000-06-02 |
| AP2001002165A0 (en) | 2001-06-30 |
| OA11717A (en) | 2005-01-26 |
| TR200101433T2 (en) | 2001-10-22 |
| EA200100586A1 (en) | 2001-12-24 |
| IL142776A0 (en) | 2002-03-10 |
| WO2000030625A3 (en) | 2000-10-05 |
| CN1328465A (en) | 2001-12-26 |
| WO2000030625A2 (en) | 2000-06-02 |
| BR9915639A (en) | 2001-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100765A3 (en) | Composition for the treatment of halitosis | |
| AU2301699A (en) | System for the treatment of wafers | |
| PL350618A1 (en) | Use of xenon for treating neurointoxications | |
| HK1038691A1 (en) | Antibiotic compositions for treatment of the eye | |
| PL342076A1 (en) | Method of treating surfaces | |
| PL342817A1 (en) | Novel derivatives of dihydroxyhexanic acid | |
| MXPA00012647A (en) | N-substituted derivatives of 5-oxyiminobarbituric acid. | |
| PL348721A1 (en) | Use of phosphonoformic acid derivatives for treating infections | |
| IL133760A0 (en) | Composition for the treatment of dandruff | |
| IL142775A0 (en) | Use of phosphonoformic acid derivatives for treating infections | |
| PL344523A1 (en) | Method for treatment of aqueous streams comprising biosolids | |
| GB2344586B (en) | Isoquinuclidine derivatives,method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds | |
| AU1940800A (en) | Combination therapy for the treatment of sepsis | |
| EP1096927A4 (en) | Composition for treatment of stress | |
| IL124764A0 (en) | Topical composition for treatment of baldness | |
| NO20006383D0 (en) | Process of treatment | |
| PL355625A1 (en) | Use of formulations for treating surfaces for temporarily improving dirt-removing behavior | |
| AU1036801A (en) | Agent for treating cephalic pain | |
| GB9922462D0 (en) | The use of triazolo-pyridazine derivatives for treating hearing loss | |
| IL124878A0 (en) | Composition for the treatment of seborrhea | |
| GB9822681D0 (en) | Method of treatment | |
| SI1068184T1 (en) | N-aryloxyethylamine derivatives for the treatment of depression | |
| AU2429200A (en) | Agent for inhibiting the regeneration of tissue | |
| GB9818295D0 (en) | Treatment of alopecia | |
| AU2270100A (en) | Method for the treatment of bone loss |